Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Luka Milas

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Procedures

Disorders

Physiology

Concepts & Ideas

Radiation Dose-Response Relationship

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Riesterer Oliver; Mason Kathryn A; Raju Uma; Yang Qiuan; Wang Li; Hittelman Walter N; Ang K Kian; Milas Luka
Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed.
Meyn Raymond E; Munshi Anapama; Haymach John V; Milas Luka; Ang K Kian
Receptor signaling as a regulatory mechanism of DNA repair.
Woodward Wendy A; Bristow Robert G; Clarke Michael F; Coppes Robert P; Cristofanilli Massimo; Duda Dan G; Fike John R; Hambardzumyan Dolores; Hill Richard P; Jordan Craig T; Milas Luka; Pajonk Frank; Curran Walter J; Dicker Adam P; Chen Yuhchyau
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Luka Milas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Riesterer Oliver; Mason Kathryn A; Raju Uma; Yang Qiuan; Wang Li; Hittelman Walter N; Ang K Kian; Milas Luka
Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):383-7.
2009: Meyn Raymond E; Munshi Anapama; Haymach John V; Milas Luka; Ang K Kian
Receptor signaling as a regulatory mechanism of DNA repair.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):316-22.
2009: Woodward Wendy A; Bristow Robert G; Clarke Michael F; Coppes Robert P; Cristofanilli Massimo; Duda Dan G; Fike John R; Hambardzumyan Dolores; Hill Richard P; Jordan Craig T; Milas Luka; Pajonk Frank; Curran Walter J; Dicker Adam P; Chen Yuhchyau
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
International journal of radiation oncology, biology, physics 2009;74(5):1580-91.
2009: Yuan Xianglin; Liao Zhongxing; Liu Zhensheng; Wang Li-E; Tucker Susan L; Mao Li; Wang Xin Shelley; Martel Mary; Komaki Ritsuko; Cox James D; Milas Luka; Wei Qingyi
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3370-8.
2009: Milas Luka; Hittelman Walter N
Cancer stem cells and tumor response to therapy: current problems and future prospects.
Seminars in radiation oncology 2009;19(2):96-105.
2009: Meyn Raymond E; Milas Luka; Ang K Kian
The role of apoptosis in radiation oncology.
International journal of radiation biology 2009;85(2):107-15.
2008: Riesterer Oliver; Milas Luka; Ang K Kian
Combining molecular therapeutics with radiotherapy for head and neck cancer.
Journal of surgical oncology 2008;97(8):708-11.
2008: Mason Kathryn A; Valdecanas David; Hunter Nancy R; Milas Luka
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.
Investigational new drugs 2008;26(1):1-5.
2008: Dittmann Klaus H; Mayer Claus; Ohneseit Petra A; Raju Uma; Andratschke Nickolaus H; Milas Luka; Rodemann H Peter
Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
International journal of radiation oncology, biology, physics 2008;70(1):203-12.
2007: Shibuya Keiko; Komaki Ritsuko; Shintani Tomoaki; Itasaka Satoshi; Ryan Anderson; Jürgensmeier Juliane M; Milas Luka; Ang Kian; Herbst Roy S; O'Reilly Michael S
Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2007;69(5):1534-43.
2007: Thariat Juliette; Milas Luka; Ang K Kian
Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer.
International journal of radiation oncology, biology, physics 2007;69(4):974-84.
2007: Wiedenmann Nicole; Koto Masashi; Raju Uma; Milas Luka; Mason Kathryn A
Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.
Investigational new drugs 2007;25(5):411-6.
2007: Riesterer Oliver; Milas Luka; Ang K Kian
Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4075-83.
2007: Zhu Guangying; Cao Xianyi; Chang Joe Y; Milas Luka; Wallace Sidney; Li Chun
Polymeric retinoid prodrug PG-4HPR enhances the radiation response of lung cancer.
Oncology reports 2007;18(3):645-51.
2007: Thariat Juliette; Yildirim Gokcen; Mason Kathryn A; Garden Adam S; Milas Luka; Ang K Kian
Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.
International journal of clinical oncology / Japan Society of Clinical Oncology 2007;12(2):99-110.
2007: Wiedenmann Nicole; Valdecanas David; Hunter Nancy; Hyde Stephen; Buchholz Thomas A; Milas Luka; Mason Kathryn A
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1868-74.
2007: Itasaka Satoshi; Komaki Ritsuko; Herbst Roy S; Shibuya Keiko; Shintani Tomoaki; Hunter Nancy R; Onn Amir; Bucana Corazon D; Milas Luka; Ang K Kian; O'Reilly Michael S
Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice.
International journal of radiation oncology, biology, physics 2007;67(3):870-8.
2007: Milas Luka; Fang Fu-Min; Mason Kathy A; Valdecanas David; Hunter Nancy; Koto Masashi; Ang K Kian
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
International journal of radiation oncology, biology, physics 2007;67(2):568-72.
2007: Liao Zhongxing; Mason Kathryn A; Milas Luka
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?
Drugs 2007;67(6):821-45.
2006: Nakata Eiko; Fukushima Masakazu; Takai Yoshihiro; Nemoto Kenji; Ogawa Yoshihiro; Nomiya Takuma; Nakamura Yasuhiro; Milas Luka; Yamada Shogo
S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
Oncology reports 2006;16(3):465-71.
2006: Mason Kathryn A; Neal Robert; Hunter Nancy; Ariga Hisanori; Ang Kian; Milas Luka
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):192-8.
2006: Raju Uma; Ariga Hisanori; Koto Masashi; Lu Xueguan; Pickett Jessica; Valdecanas David; Mason Kathryn A; Milas Luka
Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):185-91.
2006: Apisarnthanarax Smith; Alauddin Mian M; Mourtada Firas; Ariga Hisanori; Raju Uma; Mawlawi Osama; Han Dongmei; Bornmann William G; Ajani Jaffer A; Milas Luka; Gelovani Juri G; Chao K S Clifford
Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4590-7.
2006: Dipetrillo Tom; Milas Luka; Evans Devon; Akerman Paul; Ng Thomas; Miner Tom; Cruff Dennis; Chauhan Bharti; Iannitti David; Harrington David; Safran Howard
Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study.
American journal of clinical oncology 2006;29(4):376-9.
2006: Wu Xifeng; Gu Jian; Wu Tsung-Teh; Swisher Stephen G; Liao Zhongxin; Correa Arlene M; Liu Jun; Etzel Carol J; Amos Christopher I; Huang Maosheng; Chiang Silvia S; Milas Luke; Hittelman Walter N; Ajani Jaffer A
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3789-98.
2006: Horsman Michael R; Bohm Lothar; Margison Geoffrey P; Milas Luka; Rosier Jean-Francois; Safrany Geza; Selzer Edgar; Verheij Marcel; Hendry Jolyon H
Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting.
International journal of radiation oncology, biology, physics 2006;64(2):551-61.
2005: Milas Luka; Raju Uma; Liao Zhongxing; Ajani Jaffer
Targeting molecular determinants of tumor chemo-radioresistance.
Seminars in oncology 2005;32(6 Suppl 9):S78-81.
2005: Raju Uma; Ariga Hisanori; Dittmann Klaus; Nakata Eiko; Ang Kian K; Milas Luka
Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib.
International journal of radiation oncology, biology, physics 2005;63(2):520-8.
2005: Dittmann Klaus; Mayer Claus; Fehrenbacher Birgit; Schaller Martin; Raju Uma; Milas Luka; Chen David J; Kehlbach Rainer; Rodemann H Peter
Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase.
The Journal of biological chemistry 2005;280(35):31182-9.
2005: Liao Zhongxing; Komaki Ritsuko; Milas Luka; Yuan Chen; Kies Merrill; Chang Joe Y; Jeter Melenda; Guerrero Thomas; Blumenschien George; Smith Cheryl M; Fossella Frank; Brown Barry; Cox James D
A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3342-8.
2005: Komaki Ritsuko; Chang Joe Y; Wu Xifeng; Allen Pamela K; Milas Luka; Liao Zhongxing; Fossella Frank V; Travis Elizabeth; Spitz Margaret R
Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy.
Seminars in oncology 2005;32(2 Suppl 3):S92-8.
2005: Dittmann Klaus; Toulany Mahmoud; Classen Johannes; Heinrich Vanessa; Milas Luka; Rodemann H Peter
Selective radioprotection of normal tissues by Bowman-birk proteinase inhibitor (BBI) in mice.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2005;181(3):191-6.
2005: Mason Kathryn A; Ariga Hisanori; Neal Robert; Valdecanas David; Hunter Nancy; Krieg Arthur M; Whisnant John K; Milas Luka
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):361-9.
2004: Milas Luka; Mason Kathryn A; Ariga Hisanori; Hunter Nancy; Neal Robert; Valdecanas David; Krieg Arthur M; Whisnant John K
CpG oligodeoxynucleotide enhances tumor response to radiation.
Cancer research 2004;64(15):5074-7.
2004: Liao Zhongxing; Milas Luka
COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
Expert review of anticancer therapy 2004;4(4):543-60.
2004: Mason Kathy A; Hunter Nancy R; Raju Uma; Ariga Hisanori; Husain Amir; Valdecanas David; Neal Robert; Ang Kian K; Milas Luka
Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
International journal of radiation oncology, biology, physics 2004;59(4):1181-9.
2004: Nakata Eiko; Hunter Nancy; Mason Kathy; Fan Zhen; Ang K Kian; Milas Luka
C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy.
International journal of radiation oncology, biology, physics 2004;59(4):1163-73.
2004: Andratschke Nicolaus H; Dittmann Klaus H; Mason Kathryn A; Fan Zhen; Liao Zhongxing; Komaki Ritsuko; Ang K Kian; Milas Luka
Epidermal growth factor receptor as a target to improve treatment of lung cancer.
Clinical lung cancer 2004;5(6):340-52.
2004: Raben David; Bianco Cataldo; Milas Luka; Ang K Kian
Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
Seminars in radiation oncology 2004;14(2):139-52.
2004: Komaki Ritsuko; Lee Jin Soo; Milas Luka; Lee Hoon K; Fossella Frank V; Herbst Roy S; Allen Pamela K; Liao Zhongxing; Stevens Craig W; Lu Charles; Zinner Ralph G; Papadimitrakopoulou Vassiliki A; Kies Merrill S; Blumenschein George R; Pisters Katherine M; Glisson Bonnie S; Kurie Johnathan; Kaplan Bunyamin; Garza Veronica P; Mooring Deidre; Tucker Susan L; Cox James D
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
International journal of radiation oncology, biology, physics 2004;58(5):1369-77.
2004: Brock William A; Milas Luka; Bergh Sherry; Lo Ruth; Szabó Csaba; Mason Kathy A
Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase.
Cancer letters 2004;205(2):155-60.
2004: Milas Luka; Fan Zhen; Andratschke Nicolaus H; Ang K Kian
Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.
International journal of radiation oncology, biology, physics 2004;58(3):966-71.
2004: Ang K Kian; Andratschke Nicolaus H; Milas Luka
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.
International journal of radiation oncology, biology, physics 2004;58(3):959-65.
2004: Komaki Ritsuko; Liao Zhongxing; Milas Luka
Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer.
Seminars in oncology 2004;31(1 Suppl 1):47-53.
2004: Ismail Sheikh M; Puppi Monica; Prithivirajsingh Sheela; Munshi Anupama; Raju Uma; Meyn Raymond E; Buchholz Thomas A; Story Michael D; Brock William A; Milas Luka; Thames Howard D; Stevens Craig W
Predicting radiosensitivity using DNA end-binding complex analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1226-34.
2004: Nakata Eiko; Mason Kathryn A; Hunter Nancy; Husain Amir; Raju Uma; Liao Zhongxing; Ang Kian K; Milas Luka
Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.
International journal of radiation oncology, biology, physics 2004;58(2):369-75.
2003: Liang Ke; Lu Yang; Jin Weidong; Ang K Kian; Milas Luka; Fan Zhen
Sensitization of breast cancer cells to radiation by trastuzumab.
Molecular cancer therapeutics 2003;2(11):1113-20.
2003: Choy Hak; Milas Luka
Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?
Journal of the National Cancer Institute 2003;95(19):1440-52.
2003: Liang Ke; Ang K Kian; Milas Luka; Hunter Nancy; Fan Zhen
The epidermal growth factor receptor mediates radioresistance.
International journal of radiation oncology, biology, physics 2003;57(1):246-54.
2003: Liao Zhongxing; Milas Luka; Komaki Ritsuko; Stevens Craig; Cox James D
Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
American journal of clinical oncology 2003;26(4):S85-91.
2003: Crane Christopher H; Mason Kathy; Janjan Nora A; Milas Luka
Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer.
American journal of clinical oncology 2003;26(4):S81-4.
2003: Milas Luka
Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
American journal of clinical oncology 2003;26(4):S66-9.
2003: Davis Thomas W; Hunter Nancy; Trifan Ovidiu C; Milas Luka; Masferrer Jaime L
COX-2 inhibitors as radiosensitizing agents for cancer therapy.
American journal of clinical oncology 2003;26(4):S58-61.
2003: Cox James D; Schechter Naomi R; Lee Andrew K; Forster Kenneth; Stevens Craig W; Ang Kie-Kian; Komaki Ritsuko; Liao Zhongxing; Milas Luka
Uncertainties in physical and biological targeting with radiation therapy.
Rays 2003;28(3):211-5.
2003: Raju Uma; Nakata Eiko; Mason Kathy A; Ang K Kian; Milas Luka
Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Cancer research 2003;63(12):3263-7.
2003: Liao Zhongxing; Komaki Ritsuko; Mason Kathryn A; Milas Luka
Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer.
Clinical lung cancer 2003;4(6):356-65.
2003: Milas Luka; Mason Kathryn A; Crane Christopher H; Liao Zhongxing; Masferrer Jaime
Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):15-24.
2003: Liang Ke; Jin Weidong; Knuefermann Christiane; Schmidt Mathias; Mills Gordon B; Ang K Kian; Milas Luka; Fan Zhen
Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.
Molecular cancer therapeutics 2003;2(4):353-60.
2003: Milas Ivan; Komaki Ritsuko; Hachiya Tsutomu; Bubb Robbin S; Ro Jae Y; Langford Lauren; Sawaya Raymond; Putnam Joe B; Allen Pamela; Cox James D; McDonnell Timothy J; Brock William; Hong Waun Ki; Roth Jack A; Milas Luka
Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1070-6.
2003: Milas Luka; Mason Kathryn A; Hunter Nancy; Li Chun; Wallace Sidney
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.
International journal of radiation oncology, biology, physics 2003;55(3):707-12.
2003: Milas Luka; Mason Kathryn A; Liao Zhongxing; Ang Kian K
Chemoradiotherapy: emerging treatment improvement strategies.
Head & neck 2003;25(2):152-67.
2002: Grdina David J; Kataoka Yasushi; Murley Jeffrey S; Swedberg Kirsten; Lee John Y; Hunter Nancy; Weichselbaum Ralph R; Milas Luka
Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice.
Seminars in oncology 2002;29(6 Suppl 19):22-8.
2002: Ang K Kian; Berkey Brian A; Tu Xiaoyu; Zhang Hua-Zhong; Katz Ruth; Hammond Elizabeth H; Fu Karen K; Milas Luka
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
Cancer research 2002;62(24):7350-6.
2002: Rosell Rafael; Fossella Frank; Milas Luka;
Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 4():43-9.
2002: Raju Uma; Nakata Eiko; Yang Peiying; Newman Robert A; Ang Kian K; Milas Luka
In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
International journal of radiation oncology, biology, physics 2002;54(3):886-94.
2002: Nasu Sachiko; Milas Luka; Kawabe Shinichiro; Raju Uma; Newman Robert
Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process.
Cancer letters 2002;185(2):145-51.
2002: Bubb Robbin S; Komaki Ritsuko; Hachiya Tsutomu; Milas Ivan; Ro Jae Y; Langford Lauren; Sawaya Raymond; Putnam Joe B; Allen Pamela; Cox James D; McDonnell Timothy J; Brock William; Hong Waun K; Roth Jack A; Milas Luka
Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
International journal of radiation oncology, biology, physics 2002;53(5):1216-24.
2002: Milas Luka
Docetaxel/radiation combinations: rationale and preclinical findings.
Clinical lung cancer 2002;3 Suppl 2():S29-36.
2002: Crane Christopher H; Janjan Nora A; Mason Kathy; Milas Luka
Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies.
Oncology (Williston Park, N.Y.) 2002;16(5 Suppl 5):39-44.
2002: Grégoire Vincent; Ang K Kian; Rosier Jean-François; Beauduin Marc; Garden Adam S; Hamoir Marc; Hittelman Walter N; Humblet Yves; Khuri Fadlo R; Milas Luka; Mitine Carine; Scalliet Pierre
A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;63(2):187-93.
2002: Crane Christopher H; Abbruzzese James L; Evans Douglas B; Wolff Robert A; Ballo Mathew T; Delclos Marc; Milas Luka; Mason K; Charnsangavej C; Pisters P W T; Lee J E; Lenzi R; Vauthey J N; Wong A B S; Phan T; Nguyen Q; Janjan N A
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
International journal of radiation oncology, biology, physics 2002;52(5):1293-302.
2002: Milas Luka; Akimoto Tetsuo; Hunter Nancy R; Mason Kathyrn A; Buchmiller Lara; Yamakawa Michitaka; Muramatsu Hiroyuki; Ang K Kian
Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas.
International journal of radiation oncology, biology, physics 2002;52(2):514-21.
2002: Komaki R; Lee J S; Kaplan B; Allen P; Kelly J F; Liao Z; Stevens C W; Fossella F V; Zinner R; Papadimitrakopoulou V; Khuri F; Glisson B; Pisters K; Kurie J; Herbst R; Milas L; Ro J; Thames H D; Hong W K; Cox J D
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.
Seminars in radiation oncology 2002;12(1 Suppl 1):46-9.
2002: Grdina David J; Kataoka Yasushi; Murley Jeffrey S; Hunter Nancy; Weichselbaum Ralph R; Milas Luka
Inhibition of spontaneous metastases formation by amifostine.
International journal of cancer. Journal international du cancer 2002;97(2):135-41.
2001: Milas L
Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse.
Seminars in radiation oncology 2001;11(4):290-9.
2001: Nasu S; Ang K K; Fan Z; Milas L
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
International journal of radiation oncology, biology, physics 2001;51(2):474-7.
2001: Ke S; Milas L; Charnsangavej C; Wallace S; Li C
Potentiation of radioresponse by polymer-drug conjugates.
Journal of controlled release : official journal of the Controlled Release Society 2001;74(1-3):237-42.
2001: Mason K A; Komaki R; Cox J D; Milas L
Biology-based combined-modality radiotherapy: workshop report.
International journal of radiation oncology, biology, physics 2001;50(4):1079-89.
2001: Crane C H; Wolff R A; Abbruzzese J L; Evans D B; Milas L; Mason K; Charnsangavej C; Pisters P W; Lee J E; Lenzi R; Lahoti S; Vauthey J N; Janjan N A
Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.
Seminars in oncology 2001;28(3 Suppl 10):25-33.
2001: Mason K; Staab A; Hunter N; McBride W; Petersen S; Terry N; Milas L
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
International journal of oncology 2001;18(3):599-606.
2001: Crane C H; Janjan N A; Evans D B; Wolff R A; Ballo M T; Milas L; Mason K; Charnsangavej C; Pisters P W; Lee J E; Lenzi R; Vauthey J N; Wong A; Phan T; Nguyen Q; Abbruzzese J L
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.
International journal of pancreatology : official journal of the International Association of Pancreatology 2001;29(1):9-18.
2001: Phan T P; Crane C H; Janjan N A; Vrdoljak E; Milas L; Mason K A
WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment.
International journal of pancreatology : official journal of the International Association of Pancreatology 2001;29(1):19-23.
2000: Li C; Ke S; Wu Q P; Tansey W; Hunter N; Buchmiller L M; Milas L; Charnsangavej C; Wallace S
Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate.
International journal of radiation oncology, biology, physics 2000;48(4):1119-26.
2000: Nieder C; Milas L; Ang K K
Tissue tolerance to reirradiation.
Seminars in radiation oncology 2000;10(3):200-9.
2000: Li C; Ke S; Wu Q P; Tansey W; Hunter N; Buchmiller L M; Milas L; Charnsangavej C; Wallace S
Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2829-34.
2000: Petersen C; Petersen S; Milas L; Lang F F; Tofilon P J
Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2513-20.
2000: Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer J L; Tofilon P J; Milas L
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Cancer research 2000;60(5):1326-31.
2000: Oriuchi N; Jibu T; Milas L; Choe J; Kuang L; Kim E E; Hunter N R; Wallace S; Podoloff D A
Assessment of resistance to paclitaxel of murine tumors by (99m)Tc-MIBI/(201)Tl dual-radionuclide imaging.
Nuclear medicine and biology 2000;27(2):127-33.
2000: Milas L; Mason K; Hunter N; Petersen S; Yamakawa M; Ang K; Mendelsohn J; Fan Z
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):701-8.
1999: Mason K A; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4191-8.
1999: Akimoto T; Hunter N R; Buchmiller L; Mason K; Ang K K; Milas L
Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2884-90.
1999: Milas L; Kishi K; Hunter N; Mason K; Masferrer J L; Tofilon P J
Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
Journal of the National Cancer Institute 1999;91(17):1501-4.
1999: Gregoire V; Hittelman W N; Rosier J F; Milas L
Chemo-radiotherapy: radiosensitizing nucleoside analogues (review).
Oncology reports 1999;6(5):949-57.
1999: Mason K A; Milas L; Hunter N R; Elshaikh M; Buchmiller L; Kishi K; Hittelman K; Ang K K
Maximizing therapeutic gain with gemcitabine and fractionated radiation.
International journal of radiation oncology, biology, physics 1999;44(5):1125-35.
1999: Nguyen L N; Komaki R; Allen P; Schea R A; Milas L
Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
International journal of radiation oncology, biology, physics 1999;44(5):1053-6.
1999: Inoue T; Li C; Yang D J; Higuchi T; Oriuchi N; Yu D; Milas L; Hunter N; Wallace S; Kim E E; Podoloff D A
Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel.
Annals of nuclear medicine 1999;13(3):169-74.
1999: Akimoto T; Seong J; Hunter N R; Buchmiller L; Mason K; Milas L
Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.
International journal of radiation oncology, biology, physics 1999;44(2):413-9.
1999: Grdina D J; Hunter N; Kataoka Y; Murley J S; Milas L
Chemopreventive doses of amifostine confer no cytoprotection to tumor nodules growing in the lungs of mice treated with cyclophosphamide.
Seminars in oncology 1999;26(2 Suppl 7):22-7.
1999: Logsdon M D; Meyn R E; Besa P C; Pugh W C; Stephens L C; Peters L J; Milas L; Cox J D; Cabanillas F; Brisbay S; Andersen M; McDonnell T J
Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.
International journal of radiation oncology, biology, physics 1999;44(1):19-29.
1999: Li C; Price J E; Milas L; Hunter N R; Ke S; Yu D F; Charnsangavej C; Wallace S
Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):891-7.
1999: Milas L; Milas M M; Mason K A
Combination of taxanes with radiation: preclinical studies.
Seminars in radiation oncology 1999;9(2 Suppl 1):12-26.
1999: Akimoto T; Kawabe S; Grothey A; Milas L
Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.
Clinical & experimental metastasis 1999;17(2):171-6.
1999: Milas L; Fujii T; Hunter N; Elshaikh M; Mason K; Plunkett W; Ang K K; Hittelman W
Enhancement of tumor radioresponse in vivo by gemcitabine.
Cancer research 1999;59(1):107-14.
1998: Li C; Yu D F; Newman R A; Cabral F; Stephens L C; Hunter N; Milas L; Wallace S
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
Cancer research 1998;58(11):2404-9.
1998: Komaki R; Milas L; Ro J Y; Fujii T; Perkins P; Allen P; Sikes C R; Mountain C F; Ordonez N G
Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
International journal of radiation oncology, biology, physics 1998;40(4):787-96.
1997: Mason K A; Hunter N R; Milas M; Abbruzzese J L; Milas L
Docetaxel enhances tumor radioresponse in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2431-8.
1997: Milross C G; Mason K A; Hunter N R; Terry N H; Patel N; Harada S; Jibu T; Seong J; Milas L
Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1299-308.
1997: Li C; Yu D F; Inoue T; Yang D J; Tansey W; Liu C W; Milas L; Hunter N R; Kim E E; Wallace S
Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(7):1042-7.
1997: Saito Y; Milross C G; Hittelman W N; Li D; Jibu T; Peters L J; Milas L
Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction.
International journal of radiation oncology, biology, physics 1997;38(3):623-31.
1997: Seong J; Milross C G; Hunter N R; Shin H C; Milas L
Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha.
Anti-cancer drugs 1997;8(1):80-7.
1997: Meyn R E; Milas L; Stephens L C
Apoptosis in tumor biology and therapy.
Advances in experimental medicine and biology 1997;400B():657-67.
1997: Milas L; Gregoire V; Hunter N; Kurdoglu B; Mason K; Meyn R
Radiation-induced apoptosis in tumors: effect of radiation modulating agents.
Advances in experimental medicine and biology 1997;400B():559-64.
1997: Milross C G; Tucker S L; Mason K A; Hunter N R; Peters L J; Milas L
The effect of tumor size on necrosis and polarographically measured pO2.
Acta oncologica (Stockholm, Sweden) 1997;36(2):183-9.
1996: Inoue T; Yang D J; Wallace S; Cherif A; Tansey W; Kim E E; Hunter N; Milross C G; Milas L; Podoloff D A
Evaluation of [131I]iodoerythronitroimidazole as a predictor for the radiosensitizing effect.
Anti-cancer drugs 1996;7(8):858-65.
1996: Grégoire V; Hunter N R; Brock W A; Hittelman W N; Plunkett W; Milas L
Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.
Radiation research 1996;146(5):548-53.
1996: Komaki R; Fujii T; Perkins P; Ro J Y; Allen P K; Mason K A; Mountain C F; Milas L
Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer.
International journal of radiation oncology, biology, physics 1996;36(3):601-5.
1996: Milross C G; Mason K A; Hunter N R; Chung W K; Peters L J; Milas L
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel.
Journal of the National Cancer Institute 1996;88(18):1308-14.
1996: Li C; Yu D; Inoue T; Yang D J; Milas L; Hunter N R; Kim E E; Wallace S
Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug.
Anti-cancer drugs 1996;7(6):642-8.
1996: Milas L; Saito Y; Hunter N; Milross C G; Mason K A
Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(2):163-70.
1996: Thames H D; Ruifrok A C; Milas L; Hunter N; Mason K A; Terry N H; White R A
Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism.
International journal of radiation oncology, biology, physics 1996;35(5):951-62.
1996: Milas L; Milross C G; Mason K A
Cytotoxic treatments and tumor oxygenation.
The cancer journal from Scientific American 1996;2(1):59-60; author reply 60-1.
1995: Milross C G; Peters L J; Hunter N R; Mason K A; Milas L
Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo.
International journal of cancer. Journal international du cancer 1995;62(5):599-604.
1995: Milas L; Hanson W R
Eicosanoids and radiation.
European journal of cancer (Oxford, England : 1990) 1995;31A(10):1580-5.
1995: Milas L; Hunter N R; Mason K A; Milross C G; Saito Y; Peters L J
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
Cancer research 1995;55(16):3564-8.
1995: Wheeler J A; Stephens L C; Tornos C; Eifel P J; Ang K K; Milas L; Allen P K; Meyn R E
ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology.
International journal of radiation oncology, biology, physics 1995;32(5):1487-93.
1995: Mason K A; Milas L; Peters L J
Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa.
International journal of radiation oncology, biology, physics 1995;32(5):1381-9.
1995: Meyn R E; Stephens L C; Hunter N R; Milas L
Apoptosis in murine tumors treated with chemotherapy agents.
Anti-cancer drugs 1995;6(3):443-50.
1995: Meyn R E; Stephens L C; Hunter N R; Milas L
Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas.
International journal of cancer. Journal international du cancer 1995;60(5):725-9.
1995: Milas L; Hunter N R; Kurdoglu B; Mason K A; Meyn R E; Stephens L C; Peters L J
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.
Cancer chemotherapy and pharmacology 1995;35(4):297-303.
1995: Milas L; Hunter N; Mason K A; Milross C; Peters L J
Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse.
Acta oncologica (Stockholm, Sweden) 1995;34(3):409-12.
1994: Grégoire V; Van N T; Stephens L C; Brock W A; Milas L; Plunkett W; Hittelman W N
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.
Cancer research 1994;54(23):6201-9.
1994: Meyn R E; Stephens L C; Hunter N R; Ang K K; Milas L
Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors.
International journal of radiation oncology, biology, physics 1994;30(3):619-24.
1994: Mirkovic N; Meyn R E; Hunter N R; Milas L
Radiation-induced apoptosis in a murine lymphoma in vivo.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(1):11-6.
1994: Grégoire V; Hunter N; Brock W A; Milas L; Plunkett W; Hittelman W N
Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation.
International journal of radiation oncology, biology, physics 1994;30(2):363-71.
1994: Milas L; Hunter N R; Mason K A; Kurdoglu B; Peters L J
Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Cancer research 1994;54(13):3506-10.
1994: Milas L; Nakayama T; Hunter N; Jones S; Lin T M; Yamada S; Thames H; Peters L
Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(3):247-53.
1994: Ito H; Komaki R; Milas L
Protection by WR-2721 against radiation plus cis-diamminedichloroplatinum II caused injury to colonic epithelium in mice.
International journal of radiation oncology, biology, physics 1994;28(4):899-903.
1994: Pollack A; Terry N H; White R A; Cao S; Meistrich M L; Milas L
Proliferation kinetics of recruited cells in a mouse mammary carcinoma.
Cancer research 1994;54(3):811-7.
1994: Grégoire V; Hunter N; Milas L; Brock W A; Plunkett W; Hittelman W N
Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Cancer research 1994;54(2):468-74.
1994: Meyn R E; Stephens L C; Hunter N R; Milas L
Induction of apoptosis in murine tumors by cyclophosphamide.
Cancer chemotherapy and pharmacology 1994;33(5):410-4.
1993: Meyn R E; Stephens L C; Voehringer D W; Story M D; Mirkovic N; Milas L
Biochemical modulation of radiation-induced apoptosis in murine lymphoma cells.
Radiation research 1993;136(3):327-34.
1993: Mason K A; Murphy S; Milas L
Stimulation of hematopoietic cell recovery by tetrachlorodecaoxide in sublethally irradiated mice.
Radiation research 1993;136(2):229-35.
1993: Meyn R E; Stephens L C; Ang K K; Hunter N R; Brock W A; Milas L; Peters L J
Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies.
International journal of radiation biology 1993;64(5):583-91.
1993: Besa P C; Hunter N R; Milas L
Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721.
Radiation research 1993;135(1):93-7.
1993: Stephens L C; Hunter N R; Ang K K; Milas L; Meyn R E
Development of apoptosis in irradiated murine tumors as a function of time and dose.
Radiation research 1993;135(1):75-80.
1992: Hunter N; Nakayama T; Ito H; Woo S; Milas L
Combination of interleukin-2 and irradiation in therapy of murine tumors.
Clinical & experimental metastasis 1992;10(6):431-6.
1992: Brown B W; Thompson J R; Milas L
Effects of size and growth time of a murine sarcoma on its metastatic spread.
Clinical & experimental metastasis 1992;10(1):77-86.
1992: Milas L; Nishiguchi I; Hunter N; Murray D; Fleck R; Ito H; Travis E
Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin.
Advances in space research : the official journal of the Committee on Space Research (COSPAR) 1992;12(2-3):265-71.
1992: Hunter N R; Guttenberger R; Milas L
Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721.
International journal of radiation oncology, biology, physics 1992;22(4):795-8.
1991: Milas L; Yamada S; Hunter N; Guttenberger R; Thames H D
Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors.
International journal of radiation oncology, biology, physics 1991;21(5):1195-202.
1991: Nicolson G L; Custead S E; Dulski K M; Milas L
Effects of gamma irradiation on cultured rat and mouse microvessel endothelial cells: metastatic tumor cell adhesion, subendothelial matrix degradation, and secretion of tumor cell growth factors.
Clinical & experimental metastasis 1991;9(5):457-68.
1991: Stephens L C; Ang K K; Schultheiss T E; Milas L; Meyn R E
Apoptosis in irradiated murine tumors.
Radiation research 1991;127(3):308-16.
1991: Milas L; Ito H; Nakayama T; Hunter N
Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole.
Cancer research 1991;51(14):3639-42.
1991: Milas L; Hunter N; Furuta Y; Nishiguchi I; Runkel S
Antitumour effects of indomethacin alone and in combination with radiotherapy: role of inhibition of tumour angiogenesis.
International journal of radiation biology 1991;60(1-2):65-70.
1991: Runkel S; Hunter N; Milas L
An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice.
Radiation research 1991;126(2):237-43.
1990: Milas L
Tumor bed effect in murine tumors: relationship to tumor take and tumor macrophage content.
Radiation research 1990;123(2):232-6.
1990: Milas L; Furuta Y; Hunter N; Nishiguchi I; Runkel S
Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence.
Cancer research 1990;50(15):4473-7.
1990: Volpe J P; Milas L
Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases.
Clinical & experimental metastasis 1990;8(4):381-9.
1990: Murray D; Prager A; Vanankeren S C; Altschuler E M; Kerr M S; Terry N H; Milas L
Comparative effect of the thiols dithiothreitol, cysteamine and WR-151326 on survival and on the induction of DNA damage in cultured Chinese hamster ovary cells exposed to gamma-radiation.
International journal of radiation biology 1990;58(1):71-91.
1990: Nishiguchi I; Furuta Y; Hunter N; Murray D; Milas L
Radioprotection of hematopoietic tissues in mice by indomethacin.
Radiation research 1990;122(2):188-92.
1990: Nishiguchi I; Willingham V; Milas L
Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors.
International journal of radiation oncology, biology, physics 1990;18(3):555-8.
1990: Volpe J P; Basic I; Milas L
Metastatic abilities of murine sarcomas and carcinomas. II. Relationship to cell volume and DNA index.
Clinical & experimental metastasis 1990;8(2):193-201.
1989: Murray D; Altschuler E M; Hunter N; Milas L
Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
Radiation research 1989;120(2):339-51.
1989: Murray D; Prager A; Milas L
Radioprotection of cultured mammalian cells by the aminothiols WR-1065 and WR-255591: correlation between protection against DNA double-strand breaks and cell killing after gamma radiation.
Radiation research 1989;120(1):154-63.
1989: Milas L; Sersa G; Willingham V; Hunter N; Woo S
Adoptive immunotherapy as an adjunctive treatment to thoracic irradiation for pulmonary tumor deposits in mice.
Cancer research 1989;49(18):4979-82.
1989: vanAnkeren S C; Milas L; Murray D
Protection of cultured Chinese hamster ovary cells by the aminothiol WR-255591 from the lethal and DNA-damaging effects of fast neutrons.
International journal of radiation oncology, biology, physics 1989;16(5):1205-8.
1989: Iwakawa M; Tofilon P J; Arundel C; Milas L
Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
Cancer research 1989;49(7):1640-3.
1988: Ang K K; Thames H D; Jones S D; Jiang G L; Milas L; Peters L J
Proliferation kinetics of a murine fibrosarcoma during fractionated irradiation.
Radiation research 1988;116(2):327-36.
1988: Murray D; Altschuler E M; Kerr M S; Vanankeren S C; Meyn R E; Milas L
Radioprotection of cultured Chinese hamster ovary cells by WR-255591.
International journal of radiation biology 1988;54(2):269-83.
1988: Sersa G; Willingham V; Milas L
Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy.
International journal of cancer. Journal international du cancer 1988;42(1):129-34.
1988: Volpe J P; Milas L
Metastatic instability of murine tumor metastases: dependence on tumor type.
Clinical & experimental metastasis 1988;6(4):333-46.
1988: Furuta Y; Hunter N; Barkley T; Hall E; Milas L
Increase in radioresponse of murine tumors by treatment with indomethacin.
Cancer research 1988;48(11):3008-13.
1988: Furuta Y; Hall E R; Sanduja S; Barkley T; Milas L
Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin.
Cancer research 1988;48(11):3002-7.
1988: Terry N H; Ang K K; Hunter N R; Milas L
Tissue repair and repopulation in the tumor bed effect.
Radiation research 1988;114(3):621-6.
1988: Murray D; Milas L; Meyn R E
Radioprotection of mouse jejunum by WR-2721 and WR-1065: effects on DNA strand-break induction and rejoining.
Radiation research 1988;114(2):268-80.
1988: Milas L; Hirata H; Hunter N; Peters L J
Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas.
Cancer research 1988;48(8):2116-20.
1988: Iwakawa M; Milas L
The effect of N-methylformamide on radiocurability of murine tumors.
Radiation research 1988;113(1):199-203.
1988: Murray D; VanAnkeren S C; Milas L; Meyn R E
Radioprotective action of WR-1065 on radiation-induced DNA strand breaks in cultured Chinese hamster ovary cells.
Radiation research 1988;113(1):155-70.
1988: Milas L; Tofilon P; Iwakawa M
Maturational agents alone or in combination with cytotoxic agents in therapy of tumor metastases.
Advances in experimental medicine and biology 1988;233():377-83.
1988: Murray D; vanAnkeren S C; Milas L; Meyn R E
Radioprotective action of aminothiols in vitro and in vivo: comparison between effects on DNA damage and cell survival.
Pharmacology & therapeutics 1988;39(1-3):151-3.
1988: Milas L; Murray D; Brock W A; Meyn R E
Radioprotectors in tumor radiotherapy: factors and settings determining therapeutic ratio.
Pharmacology & therapeutics 1988;39(1-3):179-87.
1987: Iwakawa M; Tofilon P J; Hunter N; Stephens L C; Milas L
Antitumor and antimetastatic activity of the differentiating agent N-methylformamide in murine tumor systems.
Clinical & experimental metastasis 1987;5(4):289-300.
1987: Milas L; Iwakawa M; Hunter N
Enhancement of lung colony formation by admixing irradiated with viable tumor cells: dependence on host status.
Clinical & experimental metastasis 1987;5(3):213-7.
1987: Iwakawa M; Milas L; Hunter N; Tofilon P J
Modification of tumor and normal tissue radioresponse in mice by N-methylformamide.
International journal of radiation oncology, biology, physics 1987;13(1):55-60.
1987: Murray D; Basic I; Milas L; Meyn R E
DNA cross-linking following exposure to cis-platinum in primary and serially passaged cultured cells derived from two murine fibrosarcomas.
Cancer chemotherapy and pharmacology 1987;20(2):133-6.
1986: Milas L; Hunter N; Basic I; Volpe J P; Tofilon P J
Effect of the radiosensitizer misonidazole and the radioprotector diethyldithiocarbamate on spontaneous metastasis formation of murine tumors.
International journal of radiation oncology, biology, physics 1986;12(7):1071-4.
1985: Volpe J P; Hunter N; Basic I; Milas L
Metastatic properties of murine sarcomas and carcinomas. I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take.
Clinical & experimental metastasis 1985;3(4):281-94.
1985: Tofilon P J; Basic I; Milas L
Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
Cancer research 1985;45(5):2025-30.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Luka Milas

Research Profile (preview)

Living Beings

Chemicals & Drugs

Procedures

Disorders

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Luka Milas (preview)

All Publications